Back
Exxon Mobil Corp. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
54
XOM
Exxon Mobil Corp.
Last Price:
$123.50
Seasonality Move:
2.7%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$55.01
Seasonality Move:
-11.9%
Buy
54
Exxon Mobil Corp. (XOM)
is a Buy
Is Exxon Mobil Corp. a Buy, Sell or Hold?
-
The current Exxon Mobil Corp. [XOM] share price is $122.91. The Score for XOM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
XOM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XOM Stock Price Chart
What is Exxon Mobil Corp.'s stock price today?
-
The Exxon Mobil Corp. share price today is $122.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XOM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.
XOM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.33 | Buy |
| Relative Strength Index (14 RSI): | 58.16 | Buy |
| Chaikin Money Flow: | 14411234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (116.65 - 121.35) | Buy |
| Bollinger Bands (100): | (111.72 - 118.58) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 65.68 | Buy |
| Chaikin Money Flow: | -209678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.25 - 50.15) | Buy |
| Bollinger Bands (100): | (35.32 - 47.44) | Buy |
XOM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.54 | Buy |
| 20-day SMA: | 119.46 | Buy |
| 50-day SMA: | 117.69 | Buy |
| 200-day SMA: | 111.83 | Buy |
| 8-day EMA: | 121.17 | Buy |
| 20-day EMA: | 119.83 | Buy |
| 50-day EMA: | 117.83 | Buy |
| 200-day EMA: | 113.81 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.57 | Buy |
| 50-day SMA: | 45.67 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 48.35 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 40.28 | Buy |
Exxon Mobil Corp. Earnings Growth & XOM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $1.45 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
Exxon Mobil Corp. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||